GNRSU The Greenrose Holding Co. (PNK) down 99.999%: liquidity risk rises
GNRSU stock plunged to $0.000001 in U.S. market hours, a 99.999% drop from the previous close of $0.15. The Greenrose Holding Company Inc. (GNRSU) trades on the PNK exchange in the United States and posted volume of 145 shares as the move unfolded. This intraday collapse puts liquidity and delisting concerns front and center for investors in the cannabis-focused healthcare company. We break down price drivers, key ratios such as EPS 3.10, market cap $13.00, and what the move means for short-term holders and longer-term scenarios for GNRSU stock.
GNRSU stock intraday facts and market snapshot
GNRSU stock traded at $0.000001 during market hours, down 99.999% from the prior close of $0.15. Volume on the move was 145 shares and the reported market cap is $13.00, with 12,853,627 shares outstanding listed on PNK in the USA.
The company profile shows Greenrose Holding Company Inc. operates in the Healthcare sector, specifically Drug Manufacturers – Specialty & Generic, and lists 91 employees and a website at greenroseholdings.com.
Drivers behind the GNRSU stock drop
The most likely drivers are extreme illiquidity and thin order books typical of PNK-listed microcaps; small trades can move price dramatically with low volume. Lack of a recent earnings announcement and little public news amplify volatility for GNRSU stock.
Other common triggers in penny-name collapses include reverse splits, reporting issues, or trading suspension risk; we find no fresh SEC filing in the public profile to explain the move, which increases uncertainty.
GNRSU stock financials and valuation snapshot
Reported metrics show EPS 3.10 and book value per share 4.30, but GNRSU stock displays a market cap of $13.00, creating a mismatch between accounting metrics and market pricing. Key ratios reveal a low current ratio 0.21 and debt to equity 1.57, signalling balance sheet strain despite profitable TTM margins shown in company data.
Investors should note enterprise value listed in the data is inconsistent with the tiny market cap, suggesting data anomalies or adjustments; validate filings and recent disclosures before making decisions on GNRSU stock.
Technical, liquidity and sector risks for GNRSU stock
Trading volume of 145 shares and no reliable average volume make execution risk high; a single large order could push price to zero for GNRSU stock. Year high 0.15 and year low 0.000001 show extreme volatility and little trading depth in the cannabis sector slice where Greenrose operates.
Sector trends in cannabis and healthcare funding cycles can amplify swings; limited analyst coverage and missing price-target consensus increase event risk for GNRSU stock holders.
Meyka AI rates GNRSU with a score out of 100 and explains the grade
Meyka AI rates GNRSU with a score out of 100: 63.22 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry performance, financial growth, key metrics, and analyst consensus.
This grade is informational only and not investment advice; it reflects mixed fundamentals against acute market and liquidity risk that affect GNRSU stock.
Price targets and scenario outlook for GNRSU stock
Scenario planning produces three discrete targets: bear case $0.00 (high probability if trading halts), base recovery $0.01 (low-liquidity recovery), and optimistic recovery to the year high $0.15 under strong news or relisting. Each target ties to corporate action, regulatory clarity, or renewed market interest.
Given current trade depth, we assign highest near-term probability to the bear case, moderate probability to the $0.01 reset if management provides clear operational updates, and low probability to a sustained return to $0.15 without material positive catalysts.
Final Thoughts
GNRSU stock’s intraday collapse to $0.000001 on the PNK exchange highlights acute liquidity and information risks for microcap cannabis names. The move erased nearly all market value from a reported market cap of $13.00 and left visible gaps between accounting metrics (EPS 3.10, book value 4.30) and the market’s willingness to transact. Our scenario work shows a high-probability downside to $0.00 absent timely disclosures or a surge in buyer interest, a low-probability recovery to $0.15 tied to major corporate news, and a speculative intermediate reset near $0.01. Meyka AI’s forecast model projects $0.00 for GNRSU stock over the next 12 months, implying -100.00% against the current price of $0.000001; forecasts are model-based projections and not guarantees. For holders and traders, the priority is confirmable filings, order-book visibility, and attention to delisting or suspension notices. Use extreme caution with position sizing given the high execution and regulatory risk
FAQs
Why did GNRSU stock fall so sharply today?
GNRSU stock fell sharply due to extreme illiquidity, tiny intraday volume of 145 shares, and a lack of clear public filings or news to support bids. Thin markets on PNK names can trigger outsized percentage moves.
Is GNRSU stock likely to recover to prior levels?
Recovery to prior levels is unlikely without clear catalysts. Our scenario assigns low probability to a return to $0.15, moderate chance of a reset to $0.01, and higher probability of downside without new disclosures.
What should investors check before trading GNRSU stock?
Check recent SEC or company filings, OTC/PNK notices, visible bid sizes, and confirm average volume. Validate numbers like shares outstanding 12,853,627 and market cap $13.00 before entering a trade in GNRSU stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
